TRAVAGUS
Live / Allowed — Notice of allowance issued (as of 14 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Mar 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98462792
- Mark type
- Stylized text
- Filed
- 22 Mar 2024
- Published for opposition
- 19 Aug 2025
- Attorney of record
- Julia Anne Matheson
Goods and services
- Class 009 — Scientific and electric apparatus: Data processing apparatus; Headsets; Data collection apparatus, namely for saving physiological user data to facilitate tuning of optimal settings for future therapeutic sessions; Electronic devices for electrical impulses to nerves and tissue for non-medical purposes
- Class 010 — Medical apparatus: Apparatus and instruments for medical use, namely for physiological user data, nerve stimulation data and for stimulation pulses; Medical apparatus and instruments for electrical stimulation for transcutaneous auricular vagus nerve stimulation (taVNS); apparatus and instruments, namely medical devices for use to alleviate chronic inflammatory and chronic neuropathic pain
- Class 035 — Advertising and business services: Collection of quality metric data into computer databases for use by medical professionals and medical device manufacturers for business purposes; Analysis of quality metric data and statistics related to the use of electronic nerve stimulation apparatus and instruments for use by medical professionals and medical device manufacturers for business purposes; compilation of statistics for business or commercial purposes; providing consumer product information regarding medical apparatus and instruments used for electrical nerve stimulation; providing consumer information related to apparatus and instruments used for the treatment of chronic inflammatory and chronic neuropathic pain
- Class 044 — Medical, beauty and agricultural services: Providing medical treatment of epilepsy, depression, anxiety disorders, obesity, migraine, cluster headaches, insomnia, neuropathic pain, inflammatory pain, back pain, chronic pain, cognitive decline, inflammatory diseases, such as rheumatoid arthritis, osteoarthritis, psoriasis, diabetes mellitus type 1 and type 2, Crohn's disease, ulcerative colitis, systemic lupus erythematosus (SLE), asthma, chronic obstructive pulmonary diseases, multiple sclerosis and Alzheimer's disease, atherosclerosis, metabolic syndrome, obesitas
Owner
Prosecution history
- 23 Dec 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 09 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 09 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 09 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 10 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Sept 2024 — NON-FINAL ACTION E-MAILED